Article View: be.science
Article #413Cancer - Press Review (August 4, 2012) – Revue de presse (4 août 2012)
From: SMW
Date: Sat, 04 Aug 2012 18:29
Date: Sat, 04 Aug 2012 18:29
127 lines
6491 bytes
6491 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press Review (August 4, 2012) – Revue de presse (4 août 2012) Breast Cancer Charity Overstates Value of Mammograms: Researchers But, Komen official maintains routine screening gives best chance for improved survival. By Amanda Gardner. In U.S. News & World Report http://health.usnews.com/health-news/news/articles/2012/08/03/breast-cancer-charity-overstates-value-of-mammograms-researchers Cancer debate: Are tumors fueled by stem cells? How can a cancer come back after it's apparently been eradicated? Three new studies are bolstering a long-debated idea: that tumors contain their own pool of stem cells that can multiply and keep fueling the cancer, seeding regrowth. By Malcolm Ritter. In BusinessWeek http://www.businessweek.com/ap/2012-08-01/cancer-debate-are-tumors-fueled-by-stem-cells FDA Approves Zaltrap For Metastatic Colorectal Cancer The U.S. Food and Drug Administration Friday approved Zaltrap, a drug developed by Sanofi SA (SNY, SAN.FR) and Regeneron Pharmaceuticals Inc. (REGN) to treat advanced colon cancer. Specifically, the agency approved Zaltrap for use in combination with a chemotherapy regimen called Folfiri in patients whose cancer has spread beyond the colon. The approval is also for so-called second line therapy for use in patients previously treated with an oxaliplatin-based regimen. By Jennifer Corbett Dooren. In Wall Street Journal http://online.wsj.com/article/BT-CO-20120803-710782.html Depressive symptoms and cancer survival correlated Research from The University of Texas MD Anderson Cancer Center has found that symptoms of depression in patients with newly diagnosed metastatic kidney cancer are associated with survival and inflammatory gene regulation may explain this link. In Science Codex http://www.sciencecodex.com/ut_md_anderson_study_finds_link_between_depressive_symptoms_and_cancer_survival-96024 Aurka-to-p53 signaling: A link between stem cell regulation and cancer Findings promote further understanding of the self-renewal mechanism in embryonic stem cells. In EurekAlert (press release) http://www.eurekalert.org/pub_releases/2012-08/tmsh-asa080312.php Common Skin Cancer a Chronic Condition Risk of new lesions doubles for those with three prior basal cell carcinomas. By Barbara Bronson Gray. In U.S. News & World Report http://health.usnews.com/health-news/news/articles/2012/08/02/common-skin-cancer-a-chronic-condition-study-says Cancer du sein: une organisation accusée de trop vanter la mammographie Des experts médicaux reprochent à une fondation américaine, celle qui a popularisé le ruban rose, d'exagérer les mérites des mammographies pour le dépistage du cancer du sein, en omettant d'en évoquer les inconvénients. Dans AFP http://www.google.com/hostednews/afp/article/ALeqM5imQmXTzo19gVL5EcxxCVu5fnuGoQ?docId=CNG.a6c60b7bff4b25fd54cdf3535c59cc4d.531 Cancer du sein : autorisation de l'UE pour un nouveau traitement La société pharmaceutique suisse Novartis vient d'annoncer ce 30 juillet que la Commission européenne lui donnait l'autorisation de commercialiser son nouveau médicament contre le cancer du sein : l'Afinitor. Ce feu vert concerne uniquement le traitement des femmes post-ménopausées atteintes d'un cancer du sein avancé à récepteur hormonal positif (HR+), en combinaison avec un autre médicament, l'Exemestane. Dans MaxiSciences http://www.maxisciences.com/cancer/cancer-du-sein-autorisation-de-l-039-ue-pour-un-nouveau-traitement_art25970.html Manger moins salé pour se préserver des cancers de l'estomac Le Fonds mondial de recherche contre le cancer lance un avertissement contre la consommation excessive de sel. Dans Le Point http://www.lepoint.fr/sante/manger-moins-sale-pour-se-preserver-des-cancers-de-l-estomac-26-07-2012-1489638_40.php Le cannibalisme cellulaire pour stopper le cancer Des chercheurs marseillais ont découvert des cellules capables de stopper la croissance du cancer du pancréas. Par Annie Vergnenegre. Dans France3.fr http://provence-alpes.france3.fr/info/le-cannibalisme-cellulaire-pour-stopper-le-cancer--75045653.html Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix-Corman – InTextoResearch – Baelen (08/2012)
Technical Details
Message-ID:
<03bcb7ce-1f95-474a-b7b4-e3c25e9f70a5@k21g2000vbn.googlegroups.com>Path:
arc1-ca.pugleaf.net!g9ni2650791pbo.0!nntp.google.com!border1.nntp.dca.giganews.com!border4.nntp.dca.giganews.com!border2.nntp.dca.giganews.com!nntp.giganews.com!ctu-peer!news.nctu.edu.tw!goblin1!goblin.stu.neva.ru!postnews.google.com!k21g2000vbn.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: a254ea4a8d,6cd281527cbadcdb,start
X-Google-Attributes: gida254ea4a8d,public,usenet
X-Google-NewGroupId: yes
X-Google-Language: ENGLISH,UTF8
Received: by 10.66.88.199 with SMTP id bi7mr1702287pab.17.1344319242595;
Mon, 06 Aug 2012 23:00:42 -0700 (PDT)
Path: arc1-ca.pugleaf.net!g9ni2650791pbo.0!nntp.google.com!border1.nntp.dca.giganews.com!border4.nntp.dca.giganews.com!border2.nntp.dca.giganews.com!nntp.giganews.com!ctu-peer!news.nctu.edu.tw!goblin1!goblin.stu.neva.ru!postnews.google.com!k21g2000vbn.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (August 4, 2012) – Revue de presse (4 août 2012)
Date: Sat, 4 Aug 2012 11:29:29 -0700 (PDT)
Organization: http://groups.google.com
Lines: 127
Message-ID: <03bcb7ce-1f95-474a-b7b4-e3c25e9f70a5@k21g2000vbn.googlegroups.com>
NNTP-Posting-Host: 81.247.104.139
Mime-Version: 1.0
X-Trace: posting.google.com 1344105052 315 127.0.0.1 (4 Aug 2012 18:30:52 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 4 Aug 2012 18:30:52 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: k21g2000vbn.googlegroups.com; posting-host=81.247.104.139; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.1 (KHTML, like
Gecko) Chrome/21.0.1180.60 Safari/537.1,gzip(gfe)
Bytes: 6130
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable